By Hannah Green Eli Lilly and Co. is buying a Waltham biotech in a deal valued at around $3.2 billion. The startup being acquired is Morphic Holding Inc. (NASDAQ: MORF), a Waltham company working on treatments for chronic diseases such as types of inflammatory bowel disease. Indianapolis-based Lilly (NYSE: LLY) plans to acquire all outstanding shares of […]
By Hannah Green Moderna Inc. officially opened the doors to its new global headquarters on Wednesday, fulfilling its plan to bring its research and development operations under one roof. The Cambridge drugmaker has moved into a six-floor, 462,000-square-foot office and lab building at 325 Binney St. Moderna (Nasdaq: MRNA) first shared its intention to move into a new Cambridge […]
By Hannah Green The former CEO of Dyne Therapeutics Inc. has joined Forbion as the life sciences venture capital firm announced plans to expand its U.S. presence by opening a Boston office. Josh Brumm, formerly of Dyne and a newly named general partner at Forbion, said the Boston office “really does have a chance to impact the […]
By JLL Currently, Boston is an ideal destination for those looking to thrive in the artificial intelligence (AI) landscape as well as explore cutting-edge technology. From attracting impressive venture funding and housing renowned AI companies to fostering a supportive tough tech ecosystem, Boston showcases a combination of factors that solidify its position as a leading global […]
By Greg Ryan Four years after it was founded, Somerville startup Sublime Systems has the first commercial application of its low-carbon cement: Boston’s largest “net-zero” building, the new Amazon.com Inc. tower that’s going up in the Seaport District. Contractors for WS Development poured concrete that contained roughly three tons of Sublime cement at One Boston Wharf […]
By Thomas Seal The chief of Google’s AI business said that over time the company will spend more than $100 billion developing artificial intelligence technology — another sign of the investing arms race that has gripped Silicon Valley. Google DeepMind Chief Executive Officer Demis Hassabis was asked at a TED conference in Vancouver on Monday about a potential […]
By Isabelle Lee Good morning. Powell signals a delay to rate cuts. China tries to settle nerves about its new stock exchange rules. And the US considers more sanctions against Iran. Here’s what’s moving markets. — Isabelle Lee Staying high Federal Reserve Chair Jerome Powell said recent inflation data have indicated it will likely take longer for the central […]
By Hannah Green A 10-year-old AI drug discovery company is moving its headquarters from New York to Massachusetts. Insilico Medicine has leased space at 1000 Massachusetts Ave. in Cambridge. The company was previously based out of an office at Cure, a New York City healthcare innovation campus, where it plans to keep a presence as it expands in […]
By Lucia Maffei Can iRobot continue to spur robotics innovation even as its research and development spending is on the decline? That’s one of the big questions that emerged in the aftermath of the implosion of iRobot’s merger deal with Amazon, which forced the Bedford-based Roomba-maker to chart an alternative path to its own future while […]
By Hannah Green Novartis is once again shelling out millions to buy a subsidiary of Boston-based IFM Therapeutics. Novartis (NYSE: NVS) said on Wednesday it is acquiring all of the outstanding capital stock of IFM Due, a subsidiary company of IFM. Novartis is paying IFM $90 million upfront for this acquisition, and IFM will also be […]
